Arbutus to present at wedbush pacgrow healthcare virtual conference

Warminster, pa., aug. 03, 2021 (globe newswire) -- arbutus biopharma corporation (nasdaq: abus), a clinical-stage biopharmaceutical company primarily focused on discovering, developing and commercializing a cure for people with chronic hepatitis b virus (hbv) infection, as well as therapies to treat coronaviruses (including covid-19), today announced that the company will participate in a fireside chat at the wedbush pacgrow healthcare virtual conference on tuesday, august 10, 2021 at 4:05 pm et.
ABUS Ratings Summary
ABUS Quant Ranking